查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614050

藥物輸送市場：按給藥途徑、車輛、應用和最終用戶分類 - 全球預測 2025-2030

Drug Delivery Devices Market by Route of Administration (Inhalation, Injectable, Nasal), Vehicles (Dendrimer, Hydrogel, Liposome), Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年給藥市值為2,274.4億美元，預計2024年將達2,502.3億美元，複合年成長率為10.93%，到2030年將達到4,703.8億美元。

藥物傳輸市場包括各種旨在向人體施用治療藥物的產品。這包括吸入器、注射器、經皮吸收貼片和幫浦等設備，這些設備對於確保精確和受控的藥物傳輸至關重要。這些設備的需求源於需要連續、精確劑量的慢性疾病的流行，例如糖尿病和氣喘。這些設備用於各種環境，包括醫院、居家醫療和診所，以治療從腫瘤到呼吸系統疾病的各種疾病。在最終用途領域，我們看到以患者為中心的解決方案取得了進展，這些解決方案可以提高依從性和結果等。

主要市場統計
基準年[2023] 2274.4億美元
預測年份 [2024] 2502.3億美元
預測年份 [2030] 4703.8億美元
複合年成長率（%） 10.93%

關鍵的成長要素包括技術進步，例如整合數位健康資料的智慧給藥系統、人口老化需要更多醫療保健解決方案以及研發投資的增加。由於醫療保健基礎設施的擴大和意識的提高，亞太地區的新興市場擁有巨大的潛在機會。然而，市場面臨嚴格的監管要求、高昂的開發成本以及對設備安全性和有效性的擔憂等限制。還存在競爭性定價壓力和影響舊技術的專利到期等挑戰。

創新領域包括開發基於奈米技術的輸送系統、個人化醫療解決方案以及生物分解性和環保設備。研究標靶遞送機制以最大限度地減少副作用並提高治療效率也很重要。市場相關人員應專注於合作研究和夥伴關係，以利用技術進步並有效應對監管環境。

雖然這個市場的特點是技術創新迅速，但它也受到嚴格監管，以消費者安全和功效為核心。那些能夠足夠敏捷地將產品開發與監管標準和患者需求結合起來，同時利用數位醫療和藥物輸送不斷擴大的交叉點的公司將有望取得成功。

市場動態：揭示快速發展的藥物傳輸市場的關鍵市場洞察

供需的動態交互作用正在改變藥物輸送市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球慢性病流行導致藥物傳輸需求增加
    • 藥品和治療藥物的消費量增加
  • 市場限制因素
    • 併發症數量不斷增加，需要提供治療和藥物的專業知識
  • 市場機會
    • 藥物傳輸技術的進步
    • 越來越多採用自行注射裝置
  • 市場挑戰
    • 高階產品成本增加

波特五力：駕馭給藥市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物輸送市場的外部影響

外部宏觀環境因素在塑造給藥市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解給藥市場的競爭狀況

對藥物輸送市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣給藥市場供應商績效評估

FPNV定位矩陣是評估藥物傳輸市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了藥物輸送市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，藥物輸送市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於全球慢性病的增加，藥物輸送的需求增加
      • 藥品和治療藥物的消費量增加
    • 抑制因素
      • 提供治療和藥物所需的複雜性和專業知識增加
    • 機會
      • 藥物傳輸技術的進步
      • 越來越多採用自行注射裝置
    • 任務
      • 奢侈品成本上漲
  • 市場區隔分析
    • 給藥途徑： 為方便起見，優選口服給藥途徑。
    • 最終用戶：醫院需要能夠治療所有年齡層的綜合藥物輸送陣列
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥物輸送市場：依給藥途徑分類

  • 吸入
  • 可注射的
  • 鼻腔
  • 眼科
  • 口服
  • 話題
  • 經皮的

第7章 車輛給藥市場

  • 樹狀聚合物
  • 水凝膠
  • 脂質體
  • 介孔材料
  • 膠束
  • 奈米粒子
  • 氮氧化物酶體
  • 鷹架

第8章 藥物傳輸市場：依應用分類

  • 自體免疫疾病
  • 心血管疾病
  • 中樞神經系統疾病
  • 糖尿病
  • 感染疾病
  • 腫瘤學
  • 呼吸系統疾病

第9章 藥物輸送市場：依最終使用者分類

  • 門診手術中心/診所
  • 診斷中心
  • 家庭護理設置
  • 醫院

第10章美洲給藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太給藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的給藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 新分子裝置的精度革命增強了標靶藥物輸送
    • 新型穿戴式給藥裝置在美國推出，可望提高病患舒適度和依從性
    • 推出 UltraSafe PLUS，一種新型預填充式注射器，可提高給藥的安全性和精確度
  • 戰略分析和建議

公司名單

  • 3M Company
  • Abbott Laboratories
  • AdminMed nanoBioSciences LLC
  • AptarGroup, Inc.
  • ARx, LLC
  • Bayer AG
  • Becton, Dickinson and Company
  • BioSerenTach Inc.
  • CosMED Pharmaceutical Co., Ltd.
  • Credence MedSystems, Inc.
  • E3D Elcam Drug Delivery Devices by Elcam Medical
  • Enable Injections, Inc.
  • Gerresheimer AG
  • GlaxoSmithKline PLC
  • Innoture Medical Technology Limited
  • Kindeva Drug Delivery LP
  • Luye Pharma Group
  • Medtronic, Inc.
  • Midas Pharma GmbH
  • NanoPass Technologies Ltd.
  • Nitto Denko Corporation
  • Novartis AG
  • OraSure Technologies, Inc.
  • Owen Mumford Limited
  • Recipharm AB
  • Sparsha Pharma International Pvt. Ltd.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-B812DD5799B4

The Drug Delivery Devices Market was valued at USD 227.44 billion in 2023, expected to reach USD 250.23 billion in 2024, and is projected to grow at a CAGR of 10.93%, to USD 470.38 billion by 2030.

The drug delivery devices market encompasses a wide range of products designed to administer therapeutic agents into the human body. This includes devices like inhalers, injectors, transdermal patches, and pumps, which are crucial in ensuring precise, controlled delivery of medications. The necessity for these devices stems from the growing prevalence of chronic diseases, such as diabetes and asthma, which require continual, precision-based dosing. They find applications across hospitals, home care, and clinics, used for conditions ranging from oncology to respiratory disorders. At the end-use scope, advancements are particularly geared towards patient-centric solutions that improve adherence and outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 227.44 billion
Estimated Year [2024] USD 250.23 billion
Forecast Year [2030] USD 470.38 billion
CAGR (%) 10.93%

Key growth influencers include technological advancements like smart drug delivery systems that integrate digital health data, an aging population demanding more healthcare solutions, and increased R&D investments. Emerging markets in Asia-Pacific present robust potential opportunities due to expanding healthcare infrastructure and rising awareness. However, the market faces limitations such as stringent regulatory requirements, high-development costs, and concerns regarding device safety and efficacy. Challenges also include competition-induced pricing pressures and patent expirations affecting older technologies.

Innovation areas ripe for exploration include nanotechnology-based delivery systems, personalized medicine solutions, and the development of biodegradable, environmentally friendly devices. Research into targeted delivery mechanisms that minimize side effects and enhance therapeutic efficiency is also crucial. Market players should focus on collaborations and partnerships to leverage technological advancements and navigate regulatory landscapes effectively.

Navigating this market requires understanding its dynamic nature; while it is characterized by rapid innovation, it is also heavily regulated, with consumer safety and efficacy at its core. Companies that can align product development with regulatory standards and patient needs, while also being agile enough to capitalize on the growing intersection of digital health and drug delivery, stand poised for success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Devices Market

The Drug Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Chronic Diseases Globally Resulting in Increased Demand for Drug Delivery Devices
    • Rise in the Consumption of Drugs and Therapeutic Pharmaceuticals
  • Market Restraints
    • Increase in Complications and Expertise Required in Delivering Therapeutics and Drugs
  • Market Opportunities
    • Technology Advances in Drug Delivery Devices
    • Rising Adoption of Self Injectable Devices
  • Market Challenges
    • Increasing Cost of High End Products

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Devices Market

A detailed market share analysis in the Drug Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Devices Market

A strategic analysis of the Drug Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AdminMed nanoBioSciences LLC, AptarGroup, Inc., ARx, LLC, Bayer AG, Becton, Dickinson and Company, BioSerenTach Inc., CosMED Pharmaceutical Co., Ltd., Credence MedSystems, Inc., E3D Elcam Drug Delivery Devices by Elcam Medical, Enable Injections, Inc., Gerresheimer AG, GlaxoSmithKline PLC, Innoture Medical Technology Limited, Kindeva Drug Delivery L.P., Luye Pharma Group, Medtronic, Inc., Midas Pharma GmbH, NanoPass Technologies Ltd., Nitto Denko Corporation, Novartis AG, OraSure Technologies, Inc., Owen Mumford Limited, Recipharm AB, Sparsha Pharma International Pvt. Ltd., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Inhalation, Injectable, Nasal, Ocular, Oral, Topical, and Transdermal.
  • Based on Vehicles, market is studied across Dendrimer, Hydrogel, Liposome, Mesoporous Material, Micelle, Nanoparticle, Niosomes, and Scaffold.
  • Based on Application, market is studied across Autoimmune Diseases, Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Infectious Diseases, Oncology, and Respiratory Diseases.
  • Based on End-user, market is studied across Ambulatory Surgery Centers/Clinics, Diagnostic Centers, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Chronic Diseases Globally Resulting in Increased Demand for Drug Delivery Devices
      • 5.1.1.2. Rise in the Consumption of Drugs and Therapeutic Pharmaceuticals
    • 5.1.2. Restraints
      • 5.1.2.1. Increase in Complications and Expertise Required in Delivering Therapeutics and Drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technology Advances in Drug Delivery Devices
      • 5.1.3.2. Rising Adoption of Self Injectable Devices
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing Cost of High End Products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Route of Administration: Higher preferences of oral route of administration owing to its convenience
    • 5.2.2. End-user: Need for comprehensive array of drug delivery devices in hospitals that can cater to treatments across all age groups
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Delivery Devices Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Inhalation
  • 6.3. Injectable
  • 6.4. Nasal
  • 6.5. Ocular
  • 6.6. Oral
  • 6.7. Topical
  • 6.8. Transdermal

7. Drug Delivery Devices Market, by Vehicles

  • 7.1. Introduction
  • 7.2. Dendrimer
  • 7.3. Hydrogel
  • 7.4. Liposome
  • 7.5. Mesoporous Material
  • 7.6. Micelle
  • 7.7. Nanoparticle
  • 7.8. Niosomes
  • 7.9. Scaffold

8. Drug Delivery Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cardiovascular Diseases
  • 8.4. Central Nervous System Disorders
  • 8.5. Diabetes
  • 8.6. Infectious Diseases
  • 8.7. Oncology
  • 8.8. Respiratory Diseases

9. Drug Delivery Devices Market, by End-user

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers/Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Home Care Settings
  • 9.5. Hospitals

10. Americas Drug Delivery Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Delivery Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Revolutionizing Precision with New Molecular Device Enhances Targeted Drug Delivery
    • 13.3.2. New Wearable Drug Delivery Device Launches in U.S., Promising Enhanced Patient Comfort and Compliance
    • 13.3.3. Introducing UltraSafe PLUS, A New Pre-Filled Syringe Enhancing Safety and Precision in Medication Delivery
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. AdminMed nanoBioSciences LLC
  • 4. AptarGroup, Inc.
  • 5. ARx, LLC
  • 6. Bayer AG
  • 7. Becton, Dickinson and Company
  • 8. BioSerenTach Inc.
  • 9. CosMED Pharmaceutical Co., Ltd.
  • 10. Credence MedSystems, Inc.
  • 11. E3D Elcam Drug Delivery Devices by Elcam Medical
  • 12. Enable Injections, Inc.
  • 13. Gerresheimer AG
  • 14. GlaxoSmithKline PLC
  • 15. Innoture Medical Technology Limited
  • 16. Kindeva Drug Delivery L.P.
  • 17. Luye Pharma Group
  • 18. Medtronic, Inc.
  • 19. Midas Pharma GmbH
  • 20. NanoPass Technologies Ltd.
  • 21. Nitto Denko Corporation
  • 22. Novartis AG
  • 23. OraSure Technologies, Inc.
  • 24. Owen Mumford Limited
  • 25. Recipharm AB
  • 26. Sparsha Pharma International Pvt. Ltd.
  • 27. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DENDRIMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY LIPOSOME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MESOPOROUS MATERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MICELLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NANOPARTICLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NIOSOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SCAFFOLD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS/CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 114. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 123. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 127. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 131. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 135. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 139. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 143. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 147. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 151. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 155. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 159. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 163. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 167. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 171. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 175. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 183. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 187. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 191. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 195. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 206. DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023